FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/11/010359 [Registered on: 03/11/2017] Trial Registered Prospectively
Last Modified On: 15/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   a study to compare two methods of confirmation of placement of proseal LMA by Ultrasound and clinical methods. 
Scientific Title of Study   TO COMPARE CLINICAL VERSUS ULTRASOUND ASSESSMENT OF CORRECT PLACEMENT OF PROSEAL LARYNGEAL MASK AIRWAY: A PROSPECTIVE RANDOMISED STUDY 
Trial Acronym  USGPROSEAL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR KANIKA RUSTAGI 
Designation  D.M. student 
Affiliation  AIIMS 
Address  departement of oncoanaesthesia and palliative medicine, Dr.B.R.A.I.R.C.H. AIIMS, New Delhi

South
DELHI
110029
India 
Phone  9451124755  
Fax    
Email  drkanika1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR Rakesh Garg 
Designation  associate professor 
Affiliation  AIIMS 
Address  departement of oncoanaesthesia and palliative medicine, Dr.B.R.A.I.R.C.H. AIIMS, New Delhi

South
DELHI
110029
India 
Phone  9810394950  
Fax    
Email  drrgarg@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  DR KANIKA RUSTAGI 
Designation  D.M. student 
Affiliation  AIIMS 
Address  departement of oncoanaesthesia and palliative medicine, Dr.B.R.A.I.R.C.H. AIIMS, New Delhi

South
DELHI
110029
India 
Phone  9451124755  
Fax    
Email  drkanika1@gmail.com  
 
Source of Monetary or Material Support  
DEPT OF ONCOANAESTHESIA DR.B.R.A.IRCH, AIIMS 
 
Primary Sponsor  
Name  AIIMS 
Address  Departement of oncoanaesthesia and palliative medicine, DR.B.R.A.I.R.C.H. AIIMS 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kanika Rustagi  Dr. Kanika Rustagi  departement of oncoanaesthesia and palliative medicine, Dr.B.R.A.I.R.C.H. AIIMS, New Delhi
South
DELHI 
9451124755
9451124755
drkanika1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUE OF ETHICS COMITTEE FOR POST GRADUATE RESEARCH, AIIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  CANCER PATIENTS UNDERGOING SURGERY,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  group A   in this group we will confirm position of Proseal LMA by clinical methods alone. 
Intervention  Group B  in this group position of Proseal LMA will be confirmed by USG. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All patients of age 18- 65 years of age undergoing onco- surgery requiring general anaesthesia and supraglottic airway device (Proseal Laryngeal mask Airway, PLMA) as an airway management device will be recruited under this study 
 
ExclusionCriteria 
Details  1. Unwilling patients.
2. Patients with unfavourable airway anatomy like patient undergoing head and neck surgeries precluding use of supraglottic airway device.
3. Patients at high risk of aspiration like bowel obstruction, gastro-esophageal reflux disease (GERD).
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the use of ultrasonography as a suitable alternative to clinical assessment of PLMA for its accurate placement in patients.  AFTER PLACEMENT OF PROSEAL LMA  
 
Secondary Outcome  
Outcome  TimePoints 
1. Time taken for assessment for the correct placement of PLMA by clinical methods and ultrasonography (USG).
 
intaoperatively we will determine the time taken for assessment  
2. Malposition of PLMA at the end of procedure after positive pressure ventilation.
 
AFTER COMPLETION OF PROCEDURE 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/11/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details
Modification(s)  
NONE YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

we will conduct this study with an aim to evaluate clinical usefulness of the ultrasonographic assessment of confirmation of PLMA placement as compared to the classical clinical tests after placement. this study will be done on patients undergoing surgery in our hospital where LMA placement is feasible. we have two groups, first group where position of Proseal LMA will be confirmed by clinical methods and second group where position will be confirmed by USG, then they will be assessed by Fibreoptic Bronchoscopy for its optimal placement. Then we will compare the two techniques.  

 
Close